- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 27, 2026 | 48.27M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 47.35M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 44.77M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $1.11M |
| Capex | Q1 2026 · Mar 31, 2025 | $1.07M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$18.02M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$22.26M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $40M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $40M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $70.42M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $96.82M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $110.36M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $110.65M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $198.94M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $201.75M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $260.91M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $267.49M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $606.95M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $615.83M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.17 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.41 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.17 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.41 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $41.79M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $48.7M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $27.08M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $39.55M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $2.15M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$16.44M |
| Revenue | Q1 2026 · Mar 31, 2026 | $114.21M |
| Revenue | Q1 2026 · Mar 31, 2025 | $114.03M |